Blood-Based Screening for Colon Cancer: A Disruptive Innovation or Simply a Disruption?
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Ravi B
RB
Parikh
Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland3Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland.
Vinay
V
Prasad
D003110:Colonic Neoplasms / Q000175:diagnosis* / Q000401:mortality; D003113:Colonoscopy; D005243:Feces / Q000737:chemistry; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods / Q000706:statistics & numerical data; D008745:Methylation; D011230:Precancerous Conditions / Q000175:diagnosis; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D058112:Septins / Q000097:blood* / Q000235:genetics
C474315:SEPTIN9 protein, human; D058112:Septins